SMTL ID : 3vf8.1

Crystal Structure of Spleen Tyrosine Kinase Syk Catalytic Domain with Pyrazolylbenzimidazole Inhibitor 416

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.08 Å

Oligo State

monomer

Ligands

1 x 0JE: 3-[5-(5-ethoxy-6-fluoro-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1,1-diethylurea(Non-covalent)

0JE.1: 13 residues within 4Å: Chain A: L.35, V.43, A.58, E.107, M.108, A.109, E.110, G.112, P.113, N.157, L.159, S.169, D.170 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.35, A:L.35, A:D.170 Hydrogen bonds: A:A.109, A:A.109, A:S.169 Water bridges: A:D.170

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

McLean, L.R. et al., X-ray crystallographic structure-based design of selective thienopyrazole inhibitors for interleukin-2-inducible tyrosine kinase. Bioorg.Med.Chem.Lett. (2012)

Release Date

2012-05-02

Peptides

Tyrosine-protein kinase SYK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase SYK

Related Entries With Identical Sequence